Modern Methods of Diagnostics and Treatment of Neurodegenerative Diseases and Depression

Author:

Shusharina Natalia1,Yukhnenko Denis2,Botman Stepan1,Sapunov Viktor1ORCID,Savinov Vladimir1ORCID,Kamyshov Gleb1,Sayapin Dmitry1ORCID,Voznyuk Igor13ORCID

Affiliation:

1. Baltic Center for Neurotechnologies and Artificial Intelligence, Immanuel Kant Baltic Federal University, 236041 Kaliningrad, Russia

2. Department of Social Security and Humanitarian Technologies, N. I. Lobachevsky State University of Nizhny Novgorod, 603022 Nizhny Novgorod, Russia

3. Department of Neurology, Pavlov First Saint Petersburg State Medical University, 197022 Saint Petersburg, Russia

Abstract

This paper discusses the promising areas of research into machine learning applications for the prevention and correction of neurodegenerative and depressive disorders. These two groups of disorders are among the leading causes of decline in the quality of life in the world when estimated using disability-adjusted years. Despite decades of research, the development of new approaches for the assessment (especially pre-clinical) and correction of neurodegenerative diseases and depressive disorders remains among the priority areas of research in neurophysiology, psychology, genetics, and interdisciplinary medicine. Contemporary machine learning technologies and medical data infrastructure create new research opportunities. However, reaching a consensus on the application of new machine learning methods and their integration with the existing standards of care and assessment is still a challenge to overcome before the innovations could be widely introduced to clinics. The research on the development of clinical predictions and classification algorithms contributes towards creating a unified approach to the use of growing clinical data. This unified approach should integrate the requirements of medical professionals, researchers, and governmental regulators. In the current paper, the current state of research into neurodegenerative and depressive disorders is presented.

Funder

Agreement

Publisher

MDPI AG

Subject

Clinical Biochemistry

Reference133 articles.

1. National Institute of Health (2022, November 02). Degenerative Nerve Diseases, Available online: https://medlineplus.gov/degenerativenervediseases.html.

2. Neurodegenerative diseases;Checkoway;IARC Sci. Publ.,2011

3. World Health Organization (2022, November 02). Global Health Estimates: Leading Causes of DALYs. Available online: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/global-health-estimates-leading-causes-of-dalys.

4. Termine, A., Fabrizio, C., Strafella, C., Caputo, V., Petrosini, L., Caltagirone, C., Giardina, E., and Cascella, R. (2021). Multi-Layer Picture of Neurodegenerative Diseases: Lessons from the Use of Big Data through Artificial Intelligence. J. Pers. Med., 11.

5. Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria;Dubois;Alzheimer’s Dement.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3